decor-right

Our Unique Story

Gritstone bio is developing next-generation vaccines for cancer and infectious disease. Gritstone’s approach seeks to generate potent and durable immune responses by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on oncology and more recently extended our programs to include infectious diseases. Understanding the immune system's ability to recognize and attack critical disease targets is central to our therapeutic hypothesis, and common among our vaccine programs. We believe that activating and directing the immune system to these targets could offer an important opportunity to improve patient outcomes and eradicate disease.

Meet Gritstone bio

Gritstone bio is headquartered in Emeryville, California, with key functions located in Boston, Massachusetts and Pleasanton, California. We were founded in August 2015 and are listed on the Nasdaq Global Select Market under the ticker symbol GRTS.

Our Leadership

To deliver on the promise of our novel therapeutic approaches, we have assembled an experienced leadership team with deep expertise in each of our core disciplines of immunotherapy research, genomics and bioinformatics, clinical and regulatory development, and biomanufacturing.

View Bio
Andrew Allen, M.D., Ph.D.

Co-founder, President and Chief Executive Officer

View Bio
Celia Economides

Executive Vice President and Chief Financial Officer

View Bio
Matthew Hawryluk, Ph.D.

Executive Vice President and Chief Business Officer

View Bio
Erin E. Jones, M.S.

Executive Vice President and Chief Operating Officer

View Bio
Karin Jooss, Ph.D.

Executive Vice President and Head of Research & Development

View Bio
Stacy Proctor

Executive Vice President and Chief People Officer

Board
of Directors

Shefali Agarwal, M.D., M.P.H.
President and Chief Executive Officer at Valerio Therapeutics
Andrew Allen, M.D., Ph.D.
Co-founder, President and Chief Executive Officer of Gritstone bio, Inc.
Lawrence Corey, M.D.
Former President and Director, Fred Hutchinson Cancer Research Center
Clare Fisher
SVP of Business Development and Mergers & Acquisitions at BeiGene
Elaine V. Jones, Ph.D.
Naiyer A. Rizvi, M.D.
Chief Medical Officer at Synthekine
Stephen Webster
Former Chief Financial Officer of Spark Therapeutics, Inc.
Top